Empatica Gets FDA Clearance for Parkinson's Monitoring Platform
Empatica announced in a press release that its Empatica Health Monitoring Platform for Parkinson's has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance expands Empatica's monitoring platform into Parkinson's after its 2025 acquisition of PKG Health.
The platform uses wearable devices, a patient app, secure cloud technology, and a clinician portal to monitor symptoms over time. It provides measures for bradykinesia, dyskinesia, tremor, sleep, medication compliance, and other aspects of Parkinson's management.
The algorithms have been studied in more than 70 publications reviewed by peers and used across more than 150 hospitals and clinical sites worldwide. Empatica said the clearance is its twelfth FDA clearance.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 21 ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR Nov 21 Chelsea and Westminster Hospital launches multilingual AI avatar platform for lung cancer patients Nov 21 ChatGPT Health reaches Android, desktop and dots; health chats now follow the training setting Nov 20 OpenAI launches MedChemBench to test AI models on medicinal chemistry reasoning Nov 20 Danaher and Microsoft build an agentic platform for lab instrumentsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Elomia Health acquires Earkick, an AI wellbeing companion used by more than 250,000 people
IntelliProve raises €2.7 million to measure vital signs through any camera
ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR
Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans
Pathos AI Raises $237 Million at $3 Billion Valuation
Daily AI Brief: the AI news that matters, in your inbox.